50% versus 70%: is there a difference between these BCL2 cut-offs in immunohistochemistry for diffuse large B-cell lymphomas (DLBCL)?
Abstract Introduction The World Health Organization's (WHO) update of 2017 defines the cut-off for BCL2 in immunohistochemistry (IHC) in 50% of stained cells in diffuse large B-cell lymphomas (DLBCL). The WHO's 2017 classification, however, has no standardized value. This study analyzes as...
Saved in:
Main Authors: | Cristiano Claudino Oliveira (Author), Maria Aparecida Custódio Domingues (Author), Isabela Werneck da Cunha (Author), Fernando Augusto Soares (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified (DLBCL NOS) Presenting as Multiple Subcutaneous Nodules: An Unusual Cutaneous Presentation of Systemic Disease
by: Nika Tavberidze, et al.
Published: (2023) -
Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma
by: Sixia Huang, et al.
Published: (2019) -
Utility of reverse transcriptase - Multiplex ligation-dependant probe amplification (RT-MLPA) in the molecular classification of Diffuse Large B cell lymphoma (DLBCL) by cell-of-origin (COO)
by: Nicholas Dcunha, et al.
Published: (2023) -
Correlation Between C-MYC, BCL-2, and BCL-6 Protein Expression and Gene Translocation as Biomarkers in Diagnosis and Prognosis of Diffuse Large B-cell Lymphoma
by: YunXiang Zhang, et al.
Published: (2019) -
C-MYC and BCL2 translocation frequency in diffuse large B-cell lymphomas: A study of 97 patients
by: Bahar Akkaya, et al.
Published: (2016)